JP2023520233A5 - - Google Patents
Info
- Publication number
- JP2023520233A5 JP2023520233A5 JP2022560101A JP2022560101A JP2023520233A5 JP 2023520233 A5 JP2023520233 A5 JP 2023520233A5 JP 2022560101 A JP2022560101 A JP 2022560101A JP 2022560101 A JP2022560101 A JP 2022560101A JP 2023520233 A5 JP2023520233 A5 JP 2023520233A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- subject
- treatment
- mlpsc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020901052 | 2020-04-03 | ||
| AU2020901052A AU2020901052A0 (en) | 2020-04-03 | Method for treating hyperinflammation which comprise administering mesenchymal lineage precursor or stem cells | |
| AU2020901124 | 2020-04-08 | ||
| AU2020901124A AU2020901124A0 (en) | 2020-04-08 | Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells | |
| AU2020902312A AU2020902312A0 (en) | 2020-07-06 | Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells | |
| AU2020902312 | 2020-07-06 | ||
| AU2020902425A AU2020902425A0 (en) | 2020-07-14 | Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells | |
| AU2020902425 | 2020-07-14 | ||
| AU2020903041 | 2020-08-25 | ||
| AU2020903041A AU2020903041A0 (en) | 2020-08-25 | Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells | |
| AU2020903694A AU2020903694A0 (en) | 2020-10-12 | Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells | |
| AU2020903694 | 2020-10-12 | ||
| AU2020904312 | 2020-11-23 | ||
| AU2020904312A AU2020904312A0 (en) | 2020-11-23 | Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells | |
| PCT/EP2021/058683 WO2021198454A1 (en) | 2020-04-03 | 2021-04-01 | Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023520233A JP2023520233A (ja) | 2023-05-16 |
| JP2023520233A5 true JP2023520233A5 (enExample) | 2024-04-12 |
Family
ID=77927537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022560101A Pending JP2023520233A (ja) | 2020-04-03 | 2021-04-01 | 間葉系統前駆細胞又は幹細胞を使用する過炎症の治療方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230165904A1 (enExample) |
| EP (1) | EP4125957A1 (enExample) |
| JP (1) | JP2023520233A (enExample) |
| KR (1) | KR20220164741A (enExample) |
| CN (1) | CN115361959A (enExample) |
| AU (1) | AU2021245369A1 (enExample) |
| BR (1) | BR112022020042A2 (enExample) |
| CA (1) | CA3173216A1 (enExample) |
| WO (1) | WO2021198454A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4663241A3 (en) | 2010-10-08 | 2026-03-25 | Mesoblast International Sàrl | Enhanced msc preparations |
| AU2018372631B2 (en) | 2017-11-22 | 2025-06-05 | Mesoblast International Sarl | Cellular compositions and methods of treatment I |
| IL299997A (en) * | 2020-07-20 | 2023-03-01 | Brainstorm Cell Therapeutics Ltd | Methods and preparations for the treatment of lung conditions |
| CN112826833A (zh) * | 2020-07-30 | 2021-05-25 | 中国人民解放军总医院第五医学中心 | 间充质干细胞在制备新冠肺炎引起的肺损伤修复药物中的应用 |
| US12067745B2 (en) | 2022-09-27 | 2024-08-20 | Kla Corporation | Image pre-processing for overlay metrology using decomposition techniques |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US6251295B1 (en) | 1998-01-08 | 2001-06-26 | Nexell Therapeutics Inc. | Method for recirculation washing of blood cells |
| US20080095749A1 (en) * | 2004-03-22 | 2008-04-24 | Sudeepta Aggarwal | Mesenchymal stem cells and uses therefor |
| EP2057195A4 (en) * | 2006-08-29 | 2010-05-12 | Forhumantech Co Ltd | PHARMACEUTICAL COMPOSITION FOR THE SUPPRESSION OF APOPTOSIS AND METHOD OF ADMINISTERING THE SAME |
| EP4663241A3 (en) * | 2010-10-08 | 2026-03-25 | Mesoblast International Sàrl | Enhanced msc preparations |
| US20140134140A1 (en) * | 2012-11-09 | 2014-05-15 | Case Western Reserve University | Mesenchymal stem cell compositions for the treatment of microbial infections |
| WO2015016761A2 (en) * | 2013-08-01 | 2015-02-05 | Isletone Ab | Mscs in the treatment of inflammatory pulmonary diseases |
| JP6173157B2 (ja) * | 2013-10-02 | 2017-08-02 | 日本製薬株式会社 | Ｉｌ−１７産生抑制組成物 |
| CN110108883A (zh) * | 2018-10-27 | 2019-08-09 | 广州呼吸健康研究院 | 用于筛选与靶治疗ards患者的msc精准医学的标志物组合 |
| CN110101873A (zh) * | 2018-10-27 | 2019-08-09 | 广州呼吸健康研究院 | 一种利用il-10转基因的干细胞治疗ards的方法 |
-
2021
- 2021-04-01 CA CA3173216A patent/CA3173216A1/en active Pending
- 2021-04-01 EP EP21718517.2A patent/EP4125957A1/en active Pending
- 2021-04-01 AU AU2021245369A patent/AU2021245369A1/en active Pending
- 2021-04-01 US US17/995,385 patent/US20230165904A1/en active Pending
- 2021-04-01 WO PCT/EP2021/058683 patent/WO2021198454A1/en not_active Ceased
- 2021-04-01 JP JP2022560101A patent/JP2023520233A/ja active Pending
- 2021-04-01 BR BR112022020042A patent/BR112022020042A2/pt unknown
- 2021-04-01 CN CN202180027057.9A patent/CN115361959A/zh active Pending
- 2021-04-01 KR KR1020227037690A patent/KR20220164741A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101993254B1 (ko) | 태반 줄기 세포를 사용한 혈관신생 | |
| Curley et al. | Cryopreserved, xeno-free human umbilical cord mesenchymal stromal cells reduce lung injury severity and bacterial burden in rodent Escherichia coli–induced acute respiratory distress syndrome | |
| JP2022536964A5 (enExample) | ||
| WO2014075593A9 (zh) | 间充质干细胞注射液及其制备方法和在制备治疗溃疡性结肠炎药物中的应用 | |
| JP2011522553A5 (enExample) | ||
| Li et al. | When stem cells meet COVID-19: recent advances, challenges and future perspectives | |
| WO2014126176A1 (ja) | 炎症性疾患の予防又は治療用組成物 | |
| JP2024525479A5 (enExample) | ||
| JP2019535677A5 (enExample) | ||
| AU2023274138A1 (en) | Angiogenesis using stimulated placental stem cells | |
| JP7464737B2 (ja) | 肺上皮細胞の損傷及び／又は血管内皮細胞の損傷によって媒介される疾患の治療における低分子化合物の用途 | |
| WO2021178395A1 (en) | Fibroblast and tlr activated fibroblast treatment of viral induced acute respiratory distress syndrome | |
| CN115361959A (zh) | 用于使用间充质谱系前体或干细胞治疗过度炎症的方法 | |
| Riedel et al. | Stem cells and COVID-19: are the human amniotic cells a new hope for therapies against the SARS-CoV-2 virus? | |
| Aydin et al. | Combating COVID-19 with tissue engineering: a review | |
| JP2023517035A5 (enExample) | ||
| KR20230113523A (ko) | 코로나 폐렴으로 인한 폐손상 복구 약물의 제조에서의 간충질 줄기세포의 적용 | |
| JP2024516172A5 (enExample) | ||
| CN106038597A (zh) | 间充质干细胞在制备治疗急性肺损伤制剂中的应用 | |
| KR20190039700A (ko) | 다능성 간세포에 의한 허혈재관류 폐장애의 경감 및 치료 | |
| Widowati et al. | Allogeneic mesenchymal stem cells and its conditioned medium as a potential adjuvant therapy for COVID-19 | |
| CN111904980A (zh) | 间充质干细胞与在治疗急性肺损伤、急性呼吸窘迫症或肺纤维化中的用途 | |
| Papait et al. | Perinatal cells: A promising COVID-19 therapy? | |
| Burnell et al. | Progressive Pulmonary Hypertension in Newborn Infants: A Report of Two Cases With No Identifiable Respiratory or Cardiac Disease | |
| KR101777414B1 (ko) | 줄기세포 및/또는 전구세포의 활성화제 |